Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| MEMORY PHARMACEUTICALS CORP | 14,238,773 | reported | 30 Jun 2007 | tx 4+5,162,905−2,847,754 |
| Pacira BioSciences, Inc. | 3,290,479 | reported | 21 Nov 2011 | tx 1+461,538 |
| ARATANA THERAPEUTICS, INC. | 516,626 | reported | 17 Dec 2018 | tx 43+1,868,984−917,083 |
| Altimmune, Inc. | 205,004 | reported | 04 Jan 2017 | tx 32+405,008−180,004 |
| HELICOS BIOSCIENCES CORP | 11,111 | reported | 27 Jul 2007 | tx 1+11,111 |
| Omrix Biopharmaceuticals, Inc. | 4,000 | reported | 04 Sept 2008 | tx 8+47,750−5,500 |
| PEPLIN INC | 0 | reported | 11 Nov 2009 | tx 4−4,212,730 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Dec 2018 | SALE | ARATANA THERAPEUTICS, INC. | 46,094 | 5.85 USD | |
| 30 Oct 2018 | SALE | ARATANA THERAPEUTICS, INC. | 11,513 | 5.86 USD | |
| 21 Sept 2018 | SALE | ARATANA THERAPEUTICS, INC. | 75,000 | 6.06 USD | |
| 30 Jul 2018 | SALE | ARATANA THERAPEUTICS, INC. | 11,513 | 4.33 USD | |
| 30 Apr 2018 | SALE | ARATANA THERAPEUTICS, INC. | 11,513 | 5.00 USD | |
| 30 Jan 2018 | SALE | ARATANA THERAPEUTICS, INC. | 19,367 | 4.77 USD | |
| 25 Jan 2018 | GRANT_AWARD | ARATANA THERAPEUTICS, INC. | 135,600 | 0.00 USD | |
| 25 Jan 2018 | GRANT_AWARD | ARATANA THERAPEUTICS, INC. | 205,000 | 0.00 USD | deriv |
| 20 Dec 2017 | EXERCISE | ARATANA THERAPEUTICS, INC. | 26,667 | 3.14 USD | |
| 20 Dec 2017 | EXERCISE | ARATANA THERAPEUTICS, INC. | 26,667 | 0.00 USD | deriv |
| 10 Nov 2017 | SALE | ARATANA THERAPEUTICS, INC. | 50,000 | 7.00 USD | |
| 02 Oct 2017 | SALE | ARATANA THERAPEUTICS, INC. | 50,000 | 6.24 USD | |
| 17 Apr 2017 | SALE | ARATANA THERAPEUTICS, INC. | 50,000 | 5.54 USD | |
| 17 Apr 2017 | EXERCISE | ARATANA THERAPEUTICS, INC. | 46,666 | 3.14 USD | |
| 17 Apr 2017 | EXERCISE | ARATANA THERAPEUTICS, INC. | 46,666 | 0.00 USD | deriv |
| 27 Jan 2017 | SALE | ARATANA THERAPEUTICS, INC. | 50,000 | 7.72 USD | |
| 13 Jan 2017 | GRANT_AWARD | ARATANA THERAPEUTICS, INC. | 139,900 | 0.00 USD | |
| 13 Jan 2017 | GRANT_AWARD | ARATANA THERAPEUTICS, INC. | 185,000 | 0.00 USD | deriv |
| 04 Jan 2017 | EXERCISE | Altimmune, Inc. | 10,000 | 2.59 USD | |
| 04 Jan 2017 | EXERCISE | Altimmune, Inc. | 20,000 | 2.47 USD | |
| 04 Jan 2017 | EXERCISE | Altimmune, Inc. | 20,000 | 3.11 USD | |
| 04 Jan 2017 | EXERCISE | Altimmune, Inc. | 20,000 | 2.20 USD | |
| 04 Jan 2017 | EXERCISE | Altimmune, Inc. | 20,000 | 0.00 USD | deriv |
| 04 Jan 2017 | EXERCISE | Altimmune, Inc. | 20,000 | 0.00 USD | deriv |
| 04 Jan 2017 | EXERCISE | Altimmune, Inc. | 20,000 | 0.00 USD | deriv |
3 purchases reported after at least 12 months of silence — most recent on 19 Mar 2015.